Chief Science Officer
Dr. Brunet acts as NanoMediTech’s Chief Science Officer and is also Chairperson of the Science Advisory Board. He has been a significant personal contributor to NanoMediTech’s intellectual property portfolio and oversees the company’s commercial, product and project development, as well as developing NanoMediTech’s academic partnerships.
Dr. Brunet has substantial experience in the field of nanotechnology, in which he has specialized for more than 12 years. He has worked for Guerbet as well as for a number of startup biotech companies.
Dr. Brunet’s PhD in Biochemistry and Molecular Biology is from the Pierre and Marie Curie University, Paris.